TG Therapeutics TGTX Operating Lease Liabilities
Operating Lease Liabilities at other companies
Other financials
Where this comes from
Reported directly by TG Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:OperatingLeaseLiabilityNoncurrent.
The official record: TG Therapeutics’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about TG Therapeutics's operating lease liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is TG Therapeutics's operating lease liabilities?
- TG Therapeutics (TGTX) reported operating lease liabilities of $6.6M in Q1 2026.
- How has TG Therapeutics's operating lease liabilities changed year-over-year?
- TG Therapeutics's operating lease liabilities decreased by 16.1% year-over-year, from $7.86M to $6.6M.
- What is the long-term trend for TG Therapeutics's operating lease liabilities?
- Over 5 years (2020 to 2025), TG Therapeutics's operating lease liabilities has grown at a -7.6% compound annual growth rate (CAGR), from $10.41M to $7.02M.
- What does operating lease liabilities mean?
- The portion of lease payments due after more than one year.
- How do you interpret operating lease liabilities?
- An increase indicates long-term expansion of the company's physical footprint, which should ideally be supported by long-term revenue growth.
- How does operating lease liabilities compare across companies?
- This metric is comparable across companies with significant real estate or equipment lease portfolios.